Prevalence of transthyretin amyloid cardiomyopathy in patients with hypertrophic cardiomyopathy: Final analysis of the TTRACK study
Piriou N, Elliott P, Damy T, Barriales Villa R, Cappelli F, Munteanu C, Bahus C, Keohane D, Mallaina P, García-Pavía P
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Predictors of burden in caregivers to patients with untreated transthyretin amyloid cardiomyopathy
Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C, Cappelli F
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
Yun S, Palladini G, Anderson L, Cariou E, Wang R, Angeli F, Garcia-Pavia P
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
